Avesthagen Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Avesthagen Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013103
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevention or treatment of degenerative conditions such as diabetes, obesity, CVD and bone health. Avesthagen’s bio-agriculture products provide biotic & abiotic stress resistance, oil enhancement and developing functional foods from plants. The company also provides engineering and development, validation, strategic positioning and marketing services. It sells its products through a network of distributors in India and abroad markets. Avesthagen is headquartered in Bangalore, Karnataka, India.

Avesthagen Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Avesthagen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Avesthagen Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Avesthagen Plans To Raise US$126 Million In Financing 11
Private Equity 12
Avesthagen Plans to Raise USD126 Million in Private Equity 12
Avesthagen Plans To Raise US$60 Million From Equity Partner Fund 13
Partnerships 14
Avesthagen Enters Into Co-Development Agreement With CosmosID 14
Avesthagen Enters Into Co-Development Agreement With KUTLO-NITT 15
Acquisition 16
SAVA Medica Acquire 50% Stake In Dhanvantari Botanicals From Avesthagen 16
Avesthagen Ltd – Key Competitors 17
Avesthagen Ltd – Key Employees 18
Avesthagen Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Avesthagen Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Avesthagen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Avesthagen Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Avesthagen Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Avesthagen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Avesthagen Plans To Raise US$126 Million In Financing 11
Avesthagen Plans to Raise USD126 Million in Private Equity 12
Avesthagen Plans To Raise US$60 Million From Equity Partner Fund 13
Avesthagen Enters Into Co-Development Agreement With CosmosID 14
Avesthagen Enters Into Co-Development Agreement With KUTLO-NITT 15
SAVA Medica Acquire 50% Stake In Dhanvantari Botanicals From Avesthagen 16
Avesthagen Ltd, Key Competitors 17
Avesthagen Ltd, Key Employees 18
Avesthagen Ltd, Subsidiaries 19
Avesthagen Ltd, Joint Venture 19

★海外企業調査レポート[Avesthagen Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GoldStone Resources Ltd (GRL):企業の財務・戦略的SWOT分析
    Summary GoldStone Resources Ltd (GoldStone) is a mining and mineral exploration company. The company acquires, explores, develops and produces gold properties. It offers exploration projects such as Homase-Akrokeri permits, Manso Amenfi permits, Sangola permits, Oyem permits and Ngoutou permits, amo …
  • High Peak Royalties Ltd (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Ltd (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ohr Pharmaceutical Inc (OHRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • Columbia Sportswear Co (COLM):企業の財務・戦略的SWOT分析
    Columbia Sportswear Co (COLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Alzinova AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzinova AB (Alzinova) is a pharmaceutical company that discovers and develops therapeutics for the treatment of Alzheimer’s disease. The company develops amyloid beta CC peptide technology, which offers long-term research and development capabilities including the discovery and development …
  • Coro Mining Corp:企業の戦略・SWOT・財務情報
    Coro Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Coro Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Texas Instruments Inc (TXN):企業の財務・戦略的SWOT分析
    Texas Instruments Inc (TXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Petronet LNG Ltd (PETRONET):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronet LNG Ltd (Petronet) is an energy company with operations in the midstream sector. The company was formed as a joint venture by the Government of India to import liquefied natural gas (LNG) and set up LNG terminals in the country. Its major promoters include GAIL (India) Ltd, Oil & Na …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Portland General Electric Co (POR)-エネルギー分野:企業M&A・提携分析
    Summary Portland General Electric Company (PGE) is a vertically integrated electric utility which generates, transmits, distributes, and retails electricity. The company generates electricity from wholly and jointly owned wind, natural gas, coal and hydroelectric plants. PGE also participates in the …
  • Cedars-Sinai Medical Center-医療機器分野:企業M&A・提携分析
    Summary Cedars-Sinai Medical Center (Cedars-Sinai), formerly Kaspare Cohn Hospital is an academic and medical center that provides healthcare services for patients and medical professionals, and research and education services. The center offers treatments for various conditions such as abdominal pa …
  • Aviva Ltd.:企業の戦略・SWOT・財務分析
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Wawa Inc:企業の戦略・SWOT・財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Biomay AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomay AG (Biomay) is a developer of therapeutics for allergy that discovers disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. It provides pipeline product portfolio such as investigation candidates targeted against IgE me …
  • Northern Superior Resources Inc (SUP):企業の財務・戦略的SWOT分析
    Summary Northern Superior Resources Inc (Northern Superior) formerly Superior Diamonds Inc, is a mineral exploration company. The company's activities include acquisition and development of gold, and other mineral properties. Its projects include Croteau Est gold property, LAC surprise gold property …
  • Toei Animation Co., Ltd.:企業の戦略・SWOT・財務分析
    Toei Animation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toei Animation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nanomerics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Metropolis Healthcare Ltd-医療機器分野:企業M&A・提携分析
    Summary Metropolis Healthcare Ltd (Metropolis Healthcare) is a healthcare service provider that provides pathology testing services. The center provides tests and test combinations, which ranges from routine screening tests to specialized molecular and genetic assays. It also specializes in clinical …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆